← back to search

Irene Wapnir

Stanford Medicine · US
Area of research
Cancer Research · Oncology
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Implant and Reconstruction, Breast Lesions and Carcinomas, and CAR-T cell therapy research.
h-index
42
citations
13,086
works
211
NIH funding
primary concept
Medicine
email

Recent publications

Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
New England Journal of Medicine 2025cited by 102position: middledoi
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction
JAMA Surgery 2025cited by 14position: middledoi
Nipple‐areola‐complex preservation and obesity—Successful in stages
Microsurgery 2023cited by 8position: middledoi
Abstract P2-15-02: Omentum-Lipoaspirate Free-Flap Breast Reconstruction in Women with BMI <25
Cancer Research 2023cited by 0position: firstdoi
Abstract CT043: Feasibility study to evaluate performance of the LUM Imaging System for intraoperative detection of residual tumor in breast cancer patients receiving and not receiving neoadjuvant therapy
Cancer Research 2023cited by 0position: middledoi
56. A Novel Fat-Augmented Omentum-Based Construct Is A Superior Alternative For Unilateral And Bilateral Autologous Breast Reconstruction In Low-BMI Women
Plastic & Reconstructive Surgery Global Open 2023cited by 0position: middledoi
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin
Cancer Cell 2022cited by 209position: middledoi
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin.
2022cited by 173position: contributordoi
Abstract OT2-12-03: Pivotal study of the Lum imaging system for assisting intraoperative detection of residual cancer in the tumor bed of female patients with breast cancer: The INCITE trial
Cancer Research 2022cited by 0position: middledoi
Abstract CT259: Pivotal Study of the LUM Imaging System for assisting intraoperative detection of residual cancer in the tumor bed of female patients with breast cancer
Cancer Research 2021cited by 0position: middledoi
Novel Technique of Breast Reconstruction with Omental Fat-Augmented Free Flap Improves Donor Site Morbidity and Reduces Postoperative Narcotic Use
Journal of the American College of Surgeons 2021cited by 0position: middledoi
Abstract GS5-05: Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery
Cancer Research 2020cited by 43position: middledoi
Immediate Targeted Nipple–Areolar Complex Reinnervation: Improving Outcomes in Gender-affirming Mastectomy
Plastic & Reconstructive Surgery Global Open 2020cited by 33position: middledoi
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
2020cited by 31position: contributordoi
Immediate Targeted Nipple-Areolar Complex Re-Innervation: Improving Outcomes in Immediate Autologous Breast Reconstruction
Journal of the American College of Surgeons 2020cited by 8position: middledoi
Abstract P1-20-06: Results from the expansion into multiple institutions for training in the use of the LUM imaging system for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer clinical trial
Cancer Research 2020cited by 1position: middledoi
Abstract OT3-06-02: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
Cancer Research 2020cited by 0position: middledoi
Methotrexate in the Treatment of Idiopathic Granulomatous Mastitis
The Journal of Rheumatology 2019cited by 71position: middledoi
The Impact of Device Innovation on Clinical Outcomes in Expander-based Breast Reconstruction
Plastic & Reconstructive Surgery Global Open 2019cited by 13position: lastdoi
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
New England Journal of Medicine 2018cited by 2,587position: middledoi
Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study
Annals of Surgical Oncology 2017cited by 89position: middledoi
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ
Annals of Surgical Oncology 2016cited by 267position: middledoi
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ
Practical Radiation Oncology 2016cited by 216position: middledoi
Oncologic Procedures Amenable to Fluorescence-guided Surgery
Annals of Surgery 2016cited by 154position: middledoi
(527) An internet-based perioperative pain psychology treatment program: results of a randomized controlled trial in breast oncology surgery patients
Journal of Pain 2016cited by 4position: middledoi
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
The Lancet Oncology 2014cited by 205position: lastdoi
Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research
JNCI Journal of the National Cancer Institute 2014cited by 116position: middledoi
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition
Breast Cancer Research 2014cited by 74position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2020–2023)Dung Nguyen · Palo Alto University5 papers (2020–2023)Kelly K. Hunt · The University of Texas MD Anderson Cancer Center5 papers (2020–2023)Peter Blumencranz · University of South Florida5 papers (2020–2023)Stephanie A. Valente · Cleveland Clinic Lerner College of Medicine4 papers (2020–2022) · 4 papers (2020–2022) · 4 papers (2020–2022) · 4 papers (2020–2022) · 4 papers (2020–2022) · 4 papers (2020–2022) · 4 papers (2020–2022) · 4 papers (2020–2023)Barbara L. Smith · Harvard University4 papers (2020–2023)Beth‐Ann Lesnikoski · Baptist Cancer Center4 papers (2020–2022)Eleftherios P. Mamounas · NRG Oncology3 papers (2014–2025)Shelley Hwang · Palo Alto University3 papers (2016–2023)Yulia Zak · Palo Alto University3 papers (2021–2023)Monica M. Dua · Palo Alto University3 papers (2021–2023)Norman Wolmark · NRG Oncology3 papers (2014–2025)Sean Madden · Royal College of Surgeons in Ireland3 papers (2020–2022)